Deepa Chand

Medicine & Life Sciences

1. Pediatrics 100%
2. Nephrology 79%
3. Renal Dialysis 55%
4. Dialysis 48%
5. Child 47%
6. Continuous Renal Replacement Therapy 42%
7. Chronic Renal Insufficiency 40%
8. Blood Vessels 26%
9. Kidney 25%
10. Peritoneal Dialysis 23%
11. Nephrologists 20%
12. Central Venous Catheters 19%
13. Arteriovenous Fistula 19%
14. Transplants 19%
15. Chronic Kidney Failure 17%
16. Nephrotic Syndrome 17%
17. Registries 16%
18. Spinal Muscular Atrophy 16%
19. Spinal Muscular Atrophies of Childhood 15%
20. Fistula 14%
21. Catheters 13%
22. Steroids 12%
23. Genetic Therapy 11%
24. Anemia 11%
25. human PRMT5 protein 11%
26. Clinical Trials 11%
27. Renal Replacement Therapy 10%
28. Thrombotic Microangiopathies 9%
29. Tobacco 9%
30. Hypertension 9%
31. Maintenance 9%
32. Venous Pressure 9%
33. Left Ventricular Hypertrophy 9%
34. Mortality 9%
35. Therapeutics 9%
36. Population 8%
37. Transplant Recipients 8%
38. Pharmaceutical Preparations 8%
39. Tissue Plasminogen Activator 8%
40. Survival 8%
41. Plasmapheresis 8%
42. Fusobacterium necrophorum 8%
43. Serum 8%
44. Blood Pressure 8%
45. Safety 8%
46. Gingival Overgrowth 7%
47. HLA-DQA1 antigen 7%
48. Protein-Arginine N-Methyltransferases 7%
49. Atypical Hemolytic Uremic Syndrome 7%
50. Chemical and Drug Induced Liver Injury 7%